These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15556703)

  • 21. Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele.
    McNicholl JM; Smith DK; Qari SH; Hodge T
    Emerg Infect Dis; 1997; 3(3):261-71. PubMed ID: 9284370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency of CCR5 gene 32-basepair deletion in Croatian normal population.
    Ristić S; Starcević Cizmarević N; Brajenović-Milić B; Crnić-Martinović M; Kapović M
    Croat Med J; 2005 Aug; 46(4):693-4. PubMed ID: 16100775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the CC chemokine receptor 5 delta32 polymorphism in a Brazilian population with cutaneous leishmaniasis.
    Brajão de Oliveira K; Reiche EM; Kaminami Morimoto H; Pelegrinelli Fungaro MH; Estevão D; Pontello R; Franco Nasser T; Watanabe MA
    J Cutan Pathol; 2007 Jan; 34(1):27-32. PubMed ID: 17214851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of the CCR5 delta32 allele in Italian HIV type 1-infected and normal individuals.
    Battiloro E; Andreoni M; Parisi SG; Mura MS; Sotgiu G; Aceti A; Cossu G; Concia E; Verna R; D'Ambrosio E
    AIDS Res Hum Retroviruses; 2000 Jan; 16(2):181-2. PubMed ID: 10659057
    [No Abstract]   [Full Text] [Related]  

  • 25. Using the distribution of the CCR5-Δ32 allele in third-generation Maltese citizens to disprove the Black Death hypothesis.
    Baron B; Schembri-Wismayer P
    Int J Immunogenet; 2011 Apr; 38(2):139-43. PubMed ID: 21156032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 protecting CCR5-Delta32 allele in medieval Poland.
    Zawicki P; Witas HW
    Infect Genet Evol; 2008 Mar; 8(2):146-51. PubMed ID: 18162443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Getting personal about treating HIV.
    Neaton JD; Lane HC
    Nat Med; 2008 Apr; 14(4):369-70. PubMed ID: 18391933
    [No Abstract]   [Full Text] [Related]  

  • 28. Absence of the HIV-1 protective Delta ccr5 allele in most ethnic populations of India.
    Majumder PP; Dey B
    Eur J Hum Genet; 2001 Oct; 9(10):794-6. PubMed ID: 11781692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reappraisal of the historical selective pressures for the CCR5-Delta32 mutation.
    Duncan SR; Scott S; Duncan CJ
    J Med Genet; 2005 Mar; 42(3):205-8. PubMed ID: 15744032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Black Death and AIDS: CCR5-Delta32 in genetics and history.
    Cohn SK; Weaver LT
    QJM; 2006 Aug; 99(8):497-503. PubMed ID: 16880184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCR5 Delta32 polymorphism: associated with gallbladder cancer susceptibility.
    Srivastava A; Pandey SN; Choudhuri G; Mittal B
    Scand J Immunol; 2008 May; 67(5):516-22. PubMed ID: 18405329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of CCR5, CCR2, SDF1 and RANTES gene polymorphisms in subjects with HIV-related PML and not determined leukoencephalopathy.
    Guerini FR; Delbue S; Zanzottera M; Agliardi C; Saresella M; Mancuso R; Maserati R; Marchioni E; Gori A; Ferrante P
    Biomed Pharmacother; 2008 Jan; 62(1):26-30. PubMed ID: 17560067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of the CCR5-Delta32 HIV resistance gene in Bronze Age skeletons.
    Hummel S; Schmidt D; Kremeyer B; Herrmann B; Oppermann M
    Genes Immun; 2005 Jun; 6(4):371-4. PubMed ID: 15815693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the CCR5 Delta32 polymorphism in abdominal aortic aneurysms.
    Sandford B; Bown M; London N; Sayers R
    Int J Immunogenet; 2009 Aug; 36(4):199-205. PubMed ID: 19476483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
    Marozsan AJ; Kuhmann SE; Morgan T; Herrera C; Rivera-Troche E; Xu S; Baroudy BM; Strizki J; Moore JP
    Virology; 2005 Jul; 338(1):182-99. PubMed ID: 15935415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. More about the Viking hypothesis of origin of the delta32 mutation in the CCR5 gene conferring resistance to HIV-1 infection.
    Lucotte G; Dieterlen F
    Infect Genet Evol; 2003 Nov; 3(4):293-5. PubMed ID: 14636691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short communication. Association of the CCR5delta32 mutation with clinical response and >5-year survival following initiation of first triple antiretroviral regimen.
    Brumme ZL; Henrick BM; Brumme CJ; Hogg RS; Montaner JS; Harrigan PR
    Antivir Ther; 2005; 10(7):849-53. PubMed ID: 16312181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients.
    Melum E; Karlsen TH; Broomé U; Thorsby E; Schrumpf E; Boberg KM; Lie BA
    Tissue Antigens; 2006 Jul; 68(1):78-81. PubMed ID: 16774544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CCR5 promoter polymorphisms and HIV-1 perinatal transmission in Brazilian children.
    de Souza PR; Arraes LC; de Lima Filho JL; Bruneska D; Milanese M; Crovella S
    J Reprod Immunol; 2006 Feb; 69(1):77-84. PubMed ID: 16233918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of a mutated CCR-5 allele (delta32) among Italian healthy donors and individuals at risk of parenteral HIV infection.
    Zamarchi R; Indraccolo S; Minuzzo S; Coppola V; Gringeri A; Santagostino E; Vicenzi E; De Silvestro G; Biagiotti R; Baldassarre C; Chieco-Bianchi L; Amadori A
    AIDS Res Hum Retroviruses; 1999 Mar; 15(4):337-44. PubMed ID: 10082117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.